Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide.
Flawless balance sheet with reasonable growth potential.
Share Price & News
How has Medidata Solutions's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: MDSO has not had significant price volatility in the past 3 months.
7 Day Return
US Healthcare Services
1 Year Return
US Healthcare Services
Return vs Industry: MDSO exceeded the US Healthcare Services industry which returned 28.6% over the past year.
Return vs Market: MDSO exceeded the US Market which returned 24.7% over the past year.
Price Volatility Vs. Market
How volatile is Medidata Solutions's share price compared to the market and industry in the last 5 years?
Simply Wall St News
8 months ago | Simply Wall StDoes Medidata Solutions, Inc.'s (NASDAQ:MDSO) CEO Pay Compare Well With Peers?
8 months ago | Simply Wall StStocks Take A Hit: How Will Medidata Solutions, Inc. (NASDAQ:MDSO) Fare?
8 months ago | Simply Wall StIs Medidata Solutions, Inc.'s (NASDAQ:MDSO) Future Growth Already Accounted For In Today's Price?
Is Medidata Solutions undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: MDSO ($92.22) is trading above our estimate of fair value ($51.35)
Significantly Below Fair Value: MDSO is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: MDSO is poor value based on its PE Ratio (124.5x) compared to the Healthcare Services industry average (63x).
PE vs Market: MDSO is poor value based on its PE Ratio (124.5x) compared to the US market (18.9x).
Price to Earnings Growth Ratio
PEG Ratio: MDSO is poor value based on its PEG Ratio (3.1x)
Price to Book Ratio
PB vs Industry: MDSO is overvalued based on its PB Ratio (8.4x) compared to the US Healthcare Services industry average (3.7x).
How is Medidata Solutions forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MDSO's forecast earnings growth (40% per year) is above the savings rate (2.7%).
Earnings vs Market: MDSO's earnings (40% per year) are forecast to grow faster than the US market (14.3% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: MDSO's revenue (15% per year) is forecast to grow faster than the US market (7.5% per year).
High Growth Revenue: MDSO's revenue (15% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MDSO's Return on Equity is forecast to be low in 3 years time (16.9%).
How has Medidata Solutions performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MDSO has high quality earnings.
Growing Profit Margin: MDSO's current net profit margins (6.4%) are lower than last year (9.7%).
Past Earnings Growth Analysis
Earnings Trend: MDSO's earnings have grown significantly by 40.1% per year over the past 5 years.
Accelerating Growth: MDSO's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: MDSO had negative earnings growth (-22.7%) over the past year, making it difficult to compare to the Healthcare Services industry average (0.6%).
Return on Equity
High ROE: MDSO's Return on Equity (6.7%) is considered low.
Return on Assets
Return on Capital Employed
How is Medidata Solutions's financial position?
Financial Position Analysis
Short Term Liabilities: MDSO's short term assets ($466.2M) exceed its short term liabilities ($181.8M).
Long Term Liabilities: MDSO's short term assets ($466.2M) exceed its long term liabilities ($181.5M).
Debt to Equity History and Analysis
Debt Level: MDSO's debt to equity ratio (13.8%) is considered satisfactory.
Reducing Debt: MDSO's debt to equity ratio has reduced from 93.9% to 13.8% over the past 5 years.
Debt Coverage: MDSO's debt is well covered by operating cash flow (105.3%).
Interest Coverage: MDSO's interest payments on its debt are well covered by EBIT (16.6x coverage).
Inventory Level: MDSO has a low level of unsold assets or inventory.
Debt Coverage by Assets: MDSO's debt is covered by short term assets (assets are 5.1x debt).
What is Medidata Solutions's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: Unable to evaluate MDSO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate MDSO's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if MDSO's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if MDSO's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of MDSO's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Medidata Solutions has no CEO, or we have no data on them.
|CFO & Executive VP||4.4yrs||US$4.43m||0.19% $10.8m|
|Executive Vice President of Global Sales||3yrs||US$3.64m||0.095% $5.3m|
|Executive Officer||0yrs||US$4.66m||0.075% $4.2m|
|Executive VP||0.8yrs||no data||no data|
|Chief Scientific & Medical Advisor||0.5yrs||no data||no data|
|Head of Investors Relation||0yrs||no data||no data|
|Executive VP||11.9yrs||US$1.79m||0.14% $7.6m|
|Senior Vice President of Corporate Development||3.6yrs||no data||no data|
|Senior Vice President of Asia-Pacific Region||0yrs||no data||no data|
|Principal of Global Compliance & Strategy||0yrs||no data||no data|
Experienced Management: MDSO's management team is considered experienced (3.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.3%.
Medidata Solutions, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Medidata Solutions, Inc.
- Ticker: MDSO
- Exchange: NasdaqGS
- Founded: 1999
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: US$5.568b
- Shares outstanding: 60.38m
- Website: https://www.medidata.com
Number of Employees
- Medidata Solutions, Inc.
- 350 Hudson Street
- 9th Floor
- New York
- New York
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|MDSO||NasdaqGS (Nasdaq Global Select)||Yes||Common Stock||US||USD||Jun 2009|
|2M9||DB (Deutsche Boerse AG)||Yes||Common Stock||DE||EUR||Jun 2009|
Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company’s platform solutions include data capture and management, and trial planning and management. It also provides professional services, such as implementation, sponsor enablement, strategic consulting, partner support, and e-learning and training. The company markets and sells its cloud-based solutions through a direct sales force and through relationships with channel and strategic partners. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; academic research centers, government, and other non-profit organizations; other non-profit organizations; and contract research organizations and other entities engaged in clinical trials. The company has a strategic collaboration with Mapi Research Trust. Medidata Solutions, Inc. was founded in 1999 and is headquartered in New York, New York.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2019/10/30 00:21|
|End of Day Share Price||2019/10/28 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.